[Treatment of primary gastric non-Hodgkin's lymphoma]
1Cancer Hospital, Shanghai Medical University.
Abstract:
Fifty-five patients with primary gastric non-Hodgkin's lymphoma were treated in our hospital from 1970 to 1986. The overall 5-year survival rate was 70.5%. For patients with Stages IE and IIE, the 5-year survival rates were 90.5% and 57.1%, respectively. No significant relation to survival was observed concerning sex, age and course of disease. The important prognostic factors of primary gastric non-Hodgkin's lymphoma were: stage, histologic type, depth of invasion and mode of management. Postoperative radiation therapy with or without chemotherapy was better than surgery alone. Total 60Co abdominal irradiation by moving strip technique was better than multifield irradiation. While no evidence was in favor of post-operative radiotherapy plus chemotherapy for stage IE and IIE lesions, multi-disciplinary approach should be considered for patients at high risk of recurrence and metastasis.
Related Concept Videos
Treatment Resistant Cancers
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

